The Percept™ family of neurostimulators deliver personalized, upgradable therapy, powered by BrainSense™ technology. BrainSense™ technology† uses brain signals to provide a window into a patient's condition, in real time, over time.

Overview

The Percept™ PC and Percept™ RC neurostimulators feature BrainSense™ technology, designed to capture brain signals (local field potentials, or LFPs) using the implanted DBS lead. These signals can be recorded simultaneously while delivering therapeutic stimulation, inside and outside the clinic.

You can correlate these brain signals with stimulation and events capturing medication, symptoms, or side effects to deliver personalized, data-driven treatment and adjust as patient needs evolve.

Medtronic’s DBS Therapy is approved for 5 indications: Parkinson’s disease, essential tremor, dystonia*, obsessive-compulsive disorder* (OCD), and epilepsy. Indications vary by product, refer to product labeling for details. 
*Humanitarian Device: The effectiveness of these devices for the treatment of dystonia and obsessive-compulsive disorder has not been demonstrated.

How it works

BrainSense™ technology captures brain signals (local field potentials, or LFPs) using the implanted DBS lead. These signals can be recorded simultaneously while delivering therapeutic stimulation, inside and outside the clinic. Clinicians can also correlate these brain signals with stimulation and patient-captured events such as medication, symptoms, or side effects.

Cutting-edge technology to inform your DBS therapy decisions

The Percept family with BrainSense™ technology is the DBS system with sensing and directionality so you can access data-driven insights to tailor therapy with confidence.

BrainSense™ technology uses brain signals to provide clinicians with objective data to understand the impact of treatment decisions such as medication or stimulation changes.

The BrainSense™ suite of tools offers decision-making support to select and optimize programming configurations and support therapeutic results over time.

The tablet images below are associated with Parkinson's disease.

Select programming configurations:

BrainSense™ tool: Survey
  • Provides decision-making support to select therapeutic contact(s) or directionally shift stimulation during a monopolar review or follow-up programming sessions.

Optimize programming configurations:

BrainSense™ tool: Streaming

  • Guides stimulation for LFP power reduction and can assist in finding stimulation-related therapeutic windows.
  • Stimulation parameters can be adjusted to address potentially suboptimal therapy configurations using objective patient neurophysiologic data.

BrainSense™ tool: Thresholds

  • Clinician-defined LFP thresholds may allow for rapid assessment of the time spent with or without symptoms outside of clinic.

Support therapeutic results over time.

BrainSense™ tool: Timeline

  • Objective and personalized information from outside the clinic.
  • Observe effects of medications and stimulation changes on LFP power.

BrainSense™ tool: Events

  • A patient’s day-to-day in digital form.
  • Assess and understand the frequency and magnitude of the signal of interest of events over time.

SenSight™ directional DBS lead system

SenSight™ directional DBS lead system combines the benefits of directionality with the power of sensing. Built with proprietary materials, components, and processes, the SenSight™ directional lead and SenSight™ extension work seamlessly with the Percept™ neurostimulators to enhance detection of local field potentials (LFPs), which are 1 million times smaller than DBS stimulation pulses.1

Related products